MERCK & CO., INC (MRK)
Company Overview
Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda, Simponi , Januvia and Janumet, Bridion, Isentress, ProQuad, Gardasil, Pneumovax 23, RotaTeq and Belsomra. Merck made its biggest acquisition of Schering-Plough and sold off its Consumer Care business to Bayer. Other key acquisitions include Idenix Pharmaceuticals, Cubist Pharmaceuticals, Rigontec, ArQule and Acceleron Pharma. IMerck spun off products from its Women's Health unit, legacy drugs and biosimilar products into a new publicly traded company called Organon & Co.
Contact Details
- Address
- 2000 GALLOPING HILL ROAD
- City
- KENILWORTH
- State
- NJ
- Country
- USA
- Zip Code
- 07033
- Phone Number
- 908-740-4000
- Website
- -
Financial Highlights
-
Day Range
The price range a stock has traded at during the most recent trading period.
-
--
-
5 Day Range
The price range a stock has traded at during the previous 5 days.
-
--
-
3 Month Range
The price range a stock has traded at during the previous 3 months.
-
--
-
52 Week Range
The price range a stock has traded at during the previous 52 weeks.
-
--
-
Previous Close
The closing price of a stock from the previous day.
-
-
Open
The price of the stock at the start of today’s market opening.
-
-
Bid
The amount of money a trader is willing to pay per share for a given stock.
-
x-
-
Ask
The amount of money a seller wants per share of a given stock.
-
x-
-
Volume
The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.
-
-
Avg. Volume
The average number of shares traded in a given day.
-
-
Dividend Yield
A company's annual dividend expressed as a percentage of its current stock price.
-
-
Recent Dividend
The value a shareholder receives from a company they are invested in for holding their shares.
-
-
Beta
A measurement of the stock’s volatility in comparison to the market as a whole.
-
Shareholding
-
Shares Outstanding
Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.
-
-
Insider Shareholders
The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.
-
-
Institutional Shareholders
The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.
-
-
Market Cap
The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.
-
-
Revenue TTM
The amount of money a company has made for the trailing twelve-month period.
-
-
Net Income TTM
A measurement of how much profit they are retaining for the trailing twelve-month period.
-
-
P/E Ratio
The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.
-
-
EPS TTM
Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.
-
-
1 Year Return
A measurement of how much the stock has increased or decreased in the last year.
-
There is no stock data currently available for this time period, please select another option.
Please wait, gathering market data...